Rybrevant 350 mg/7 ml, Konzentrat zur Herstellung einer Infusionslösung
7680683800017
CH-68380
Konzentrat
Associated product:
RYBREVANT conc perf 350 mg/7ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
350.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
17.0 UG | Substance | HBESI |
Reimbursement information
Public price
CHF 1299.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2022
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 68380
- Drug name
- Rybrevant, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FX18
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 20/01/2022
- Authorization expiration date
- 01/05/2029
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- RYBREVANT conc perf 350 mg/7ml
- Description (DE)
- RYBREVANT Inf Konz 350 mg/7ml
- Market launch
- 20/01/2022
- Narcotic (BTM)
- No